Kaleido Biosciences Inc
Change company Symbol lookup
Select an option...
KLDO Kaleido Biosciences Inc
TRSSX T. Rowe Price Institutional Small-Cap Stock Fund
SSSS SuRo Capital Corp
AVD American Vanguard Corp
VMVFX Vanguard Global Minimum Volatility Fund Investor Shares
IO ION Geophysical Corp
DNRCQ Denbury Resources Inc
MSFT Microsoft Corp
BCRX BioCryst Pharmaceuticals Inc
WMT WALMART STORES INC
Go

Health Care : Pharmaceuticals |
Company profile

Kaleido Biosciences, Inc. is a clinical-stage healthcare company focused on leveraging the potential of the microbiome organ to treat disease and improve human health. The Company’s product candidates are Microbiome Metabolic Therapies (MMTs), which are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the organ’s existing microbes. Its proprietary product platform includes ex vivo screening of microbiome samples from healthy volunteers, ex vivo testing of patient microbiome samples and advancement of its MMT candidates into non- Investigational New Drug Application (IND) human clinical studies. Its ex vivo screening process combines advances in drug discovery with microbiome science.

Price
Delayed
$8.22
Day's Change
-0.29 (-3.41%)
Bid
--
Ask
--
B/A Size
--
Day's High
8.50
Day's Low
8.11
Volume
(Below Average)

Today's volume of 25,238 shares is on pace to be lower than KLDO's 10-day average volume of 188,738 shares.

25,238
  • Prev Close
    8.51
  • Today's Open
    8.50
  • Day's Range
    8.11-8.50
  • Avg Vol (10-day)
    188.7K
  • Last (time)
    10:15a ET 08/14/20
  • Last (size)
    120
  • 52-Wk Range
    2.82 - 10.00
    LowHigh
  • (02/10/20 - 03/13/20)
    17.80%
  • 102.9%
  • Market Cap
    292.2M
  • Shares Outstanding
    35.5M
  • -2.62
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 74.49
  • (% of float 07/31/20)
    7.09

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.